We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

49 hedge funds and large institutions have $38.4M invested in Eterna Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

510% more call options, than puts

Call options by funds: $299K | Put options by funds: $49K

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

4% more funds holding

Funds holding: 47 → 49 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

23% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 13

26% less capital invested

Capital invested by funds: $52.1M → $38.4M (-$13.6M)

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
10
Reduced
13
Closed
8
Calls
$299K
Puts
$49K
Net Calls
+$250K
Net Calls Change
-$77K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$13.9M
2
Renaissance Technologies
Renaissance Technologies
New York
+$721K
3
BlackRock
BlackRock
New York
+$607K
4
JP Morgan Chase
JP Morgan Chase
New York
+$569K
5
Morgan Stanley
Morgan Stanley
New York
+$455K

Top Sellers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
-$474K
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$304K
3
Two Sigma Investments
Two Sigma Investments
New York
-$304K
4
Bank of America
Bank of America
North Carolina
-$190K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$94K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$79K -$75.9K -4 -44%
BWP
27
Baldwin Wealth Partners
Massachusetts
$79K – – –
Two Sigma Investments
28
Two Sigma Investments
New York
$78K -$304K -16 -76%
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$75K +$94.9K +5 New
RJA
30
Raymond James & Associates
Florida
$67K -$474K -25 -86%
SFI
31
Susquehanna Fundamental Investments
Pennsylvania
$66K -$19K -1 -20%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$52K +$19K +1 +50%
Deutsche Bank
33
Deutsche Bank
Germany
$35K -$19K -1 -33%
TSS
34
Two Sigma Securities
New York
$32K +$37.9K +2 New
State Board of Administration of Florida Retirement System
35
State Board of Administration of Florida Retirement System
Florida
$31K – – –
AIG
36
American International Group
New York
$30K – – –
UBS Group
37
UBS Group
Switzerland
$28K – – –
Jane Street
38
Jane Street
New York
$27K -$56.9K -3 -60%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$27K – – –
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$26K – – –
Russell Investments Group
41
Russell Investments Group
United Kingdom
$25K +$37.9K +2 New
AFG
42
Allegheny Financial Group
Pennsylvania
$24K – – –
Invesco
43
Invesco
Georgia
$23K – – –
ProShare Advisors
44
ProShare Advisors
Maryland
$22K -$19K -1 -50%
VOYA Investment Management
45
VOYA Investment Management
Georgia
$22K – – –
TRCT
46
Tower Research Capital (TRC)
New York
$19K +$19K +1 New
SO
47
STRS Ohio
Ohio
$13K – – –
AB
48
Amalgamated Bank
New York
$10K +$19K +1 New
AF
49
Amalgamated Financial
New York
$10K +$19K +1 New
Legal & General Group
50
Legal & General Group
United Kingdom
$6K – – –
1
2
3

ERNA Hedge Fund Activity: Q1 2022 in Review

49 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2022, worth a combined $38.4M — down 26% from $52.1M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ERNA positions and 8 closed out — a net gain of 2 holders — while 10 added to existing stakes and 13 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $13.9M. The largest seller was Raymond James & Associates, cutting an estimated $474K.

  • 49 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2022, up from 47 in Q4 2021.
  • Funds reported $38.4M of Eterna Therapeutics stock for Q1 2022, down 26% quarter-over-quarter.
  • 10 funds opened new Eterna Therapeutics positions in Q1 2022 and 8 closed out, a net change of +2 holders.
  • The largest Eterna Therapeutics buyer in Q1 2022 was Armistice Capital, an estimated $13.9M added.
  • The largest Eterna Therapeutics seller in Q1 2022 was Raymond James & Associates, an estimated $474K sold.

Based on aggregated 13F filings for Q1 2022.